Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4(+) immune cells

The goal of this study was to develop and characterize an intravaginal nanomedicine for the active targeted delivery of saquinavir (SQV) to CD4(+) immune cells as a potential strategy to prevent or reduce HIV infection. The nanomedicine was formulated into a vaginal gel to provide ease in self-admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sidi, Chen, Yufei, Gu, Kaien, Dash, Alicia, Sayre, Casey L, Davies, Neal M, Ho, Emmanuel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743644/
https://www.ncbi.nlm.nih.gov/pubmed/23966779
http://dx.doi.org/10.2147/IJN.S46958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743644/
https://www.ncbi.nlm.nih.gov/pubmed/23966779
http://dx.doi.org/10.2147/IJN.S46958

Ejemplares similares